102. Jones GR, Imam SK. Validation of the revised MDRD formula and the
original Cockcroft and Gault formula for estimation of the glomerular
filtration rate using Australian data. Pathology 2009; 41: 379–382.
103. Jones GR. Use of the CKD-EPI equation for estimation of GFR in an
Australian cohort. Pathology 2010; 42: 487–488.
104. Cirillo M, Lombardi C, Luciano MG et al. Estimation of GFR: a comparison
of new and established equations. Am J Kidney Dis 2010; 56: 802–804.
105. Eriksen BO, Mathisen UD, Melsom T et al. Cystatin C is not a better
estimator of GFR than plasma creatinine in the general population.
Kidney Int 2010; 78: 1305–1311.
106. Redal-Baigorri B, Stokholm KH, Rasmussen K et al. Estimation of kidney
function in cancer patients. Dan Med Bull 2011; 58: A4236.
107. Matsushita K, Mahmoodi BK, Woodward M et al. Comparison of risk
prediction using the CKD-EPI equation and the MDRD study equation for
estimated glomerular filtration rate. JAMA 2012; 307: 1941–1951.
108. Rule AD, Teo BW. GFR estimation in Japan and China: what accounts for
the difference? Am J Kidney Dis 2009; 53: 932–935.
109. Stevens LA, Claybon MA, Schmid CH et al. Evaluation of the Chronic
Kidney Disease Epidemiology Collaboration equation for estimating the
glomerular filtration rate in multiple ethnicities. Kidney Int 2011; 79:
555–562.
110. Yeo Y, Han DJ, Moon DH et al. Suitability of the IDMS-traceable MDRD
equation method to estimate GFR in early postoperative renal transplant
recipients. Nephron Clin Pract 2010; 114: c108–117.
111. van Deventer HE, George JA, Paiker JE et al. Estimating glomerular filtration
rate in black South Africans by use of the modification of diet in renal
disease and Cockcroft-Gault equations. Clin Chem 2008; 54: 1197–1202.
112. Teo BW, Xu H, Wang D et al. GFR estimating equations in a multiethnic
Asian population. Am J Kidney Dis 2011; 58: 56–63.
113. Inker LA, Schmid CH, Tighiouart H et al. Estimating glomerular filtration
rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20–29.
114. Peralta CA, Shlipak MG, Judd S et al. Detection of chronic kidney disease
with creatinine, cystatin C, and urine albumin-to-creatinine ratio and
association with progression to end-stage renal disease and mortality.
JAMA 2011; 305: 1545–1552.
115. Schwartz GJ, Schneider MF, Maier PS et al.
Improved equations estima-
ting GFR in children with chronic kidney disease using an immuno-
nephelometric determination of cystatin C. Kidney Int 2012; 82: 445–453.
116. Inker LA, Eckfeldt J, Levey AS et al. Expressing the CKD-EPI (Chronic
Kidney Disease Epidemiology Collaboration) cystatin C equations for
estimating GFR with standardized serum cystatin C values. Am J Kidney
Dis 2011; 58: 682–684.
117. Stevens LA, Coresh J, Schmid CH et al. Estimating GFR using serum cystatin
C alone and in combination with serum creatinine: a pooled analysis of
3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395–406.
118. Zappitelli M, Parvex P, Joseph L et al. Derivation and validation of
cystatin C-based prediction equations for GFR in children. Am J Kidney
Dis 2006; 48: 221–230.
119. Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be
replaced by cystatin C formula? Pediatr Nephrol 2003; 18: 981–985.
120. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C,
plasma creatinine and the Cockcroft and Gault formula for the estimation of
glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024–2031.
121. Kwong YT, Stevens LA, Selvin E et al. Imprecision of urinary iothalamate
clearance as a gold-standard measure of GFR decreases the diagnostic
accuracy of kidney function estimating equations. Am J Kidney Dis 2010;
56: 39–49.
122. Lamb EJ, Price CP. Kidney function tests. In: Burtis CA, Ashwood E, (eds.)
Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics,
5
th
edition, Elsevier, 2012, pp 669–708.
123. Ballantyne FC, Gibbons J, O’Reilly DS. Urine albumin should replace total
protein for the assessment of glomerular proteinuria. Ann Clin Biochem
1993; 30 (Pt 1): 101–103.
124. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected
and measured? Ann Clin Biochem 2009; 46: 205–217.
125. Newman DJ, Thakkar H, Medcalf EA et al. Use of urine albumin
measurement as a replacement for total protein. Clin Nephrol 1995; 43:
104–109.
125a . Hallan SI, Ritz E, Lydersen S et al. Combining GFR and albuminuria to classify
CKD improves prediction of ESRD. JAmSocNephrol2009; 20: 1069–1077.
125b. Brantsma AH, Bakker SJ, Hillege HL et al. Cardiovascular and renal
outcome in subjects with K/DOQI stage 1–3 chronic kidney disease: the
importance of urinary albumin excretion. Nephrol Dial Transplant 2008;
23: 3851–3858.
126. Dawnay A, Wilson AG, Lamb E et al. Microalbuminuria in systemic
sclerosis. Ann Rheum Dis 1992; 51: 384–388.
127. Gross JL, de Azevedo MJ, Silveiro SP et al. Diabetic nephropathy:
diagnosis, prevention, and treatment. Diabetes Care 2005; 28: 164–176.
128. Ninomiya T, Perkovic V, de Galan BE et al. Albuminuria and kidney
function independently predict cardiovascular and renal outcomes in
diabetes. J Am Soc Nephrol 2009; 20: 1813–1821.
129. Shihabi ZK, Konen JC, O’Connor ML. Albuminuria vs urinary total protein
for detecting chronic renal disorders. Clin Chem 1991; 37: 621–624.
130. Martin H. Laboratory measurement of urine albumin and urine
total protein in screening for proteinuria in chronic kidney disease.
Clin Biochem Rev 2011; 32: 97–102.
131. Waugh J, Bell SC, Kilby M et al. Effect of concentration and biochemical
assay on the accuracy of urine dipsticks in hypertensive pregnancies.
Hypertens Pregnancy 2001; 20: 205–217.
132. Waugh J, Bell SC, Kilby MD et al. Urine protein estimation in hypertensive
pregnancy: which thresholds and laboratory assay best predict clinical
outcome? Hypertens Pregnancy 2005; 24: 291–302.
133. McElderry LA, Tarbit IF, Cassells-Smith AJ. Six methods for urinary protein
compared. Clin Chem 1982; 28: 356–360.
134. Nishi HH, Elin RJ. Three turbidimetric methods for determining total
protein compared. Clin Chem 1985;
31: 1377–1380.
135. Sedmak JJ, Grossberg SE. A rapid, sensitive, and versatile assay for protein
using Coomassie brilliant blue G250. Anal Biochem 1977; 79: 544–552.
136. de Keijzer MH, Klasen IS, Branten AJ et al. Infusion of plasma expanders
may lead to unexpected results in urinary protein assays. Scand J Clin Lab
Invest 1999; 59: 133–137.
137. Marshall T, Williams KM. Extent of aminoglycoside interference in the
pyrogallol red-molybdate protein assay depends on the concentration
of sodium oxalate in the dye reagent. Clin Chem 2004; 50: 934–935.
138. Yilmaz FM, Yucel D. Effect of addition of hemolysate on urine and
cerebrospinal fluid assays for protein. Clin Chem 2006; 52: 152–153.
139. Chambers RE, Bullock DG, Whicher JT. External quality assessment of
total urinary protein estimation in the United Kingdom. Ann Clin Biochem
1991; 28 (Pt 5): 467–473.
140. Heick HM, Begin-Heick N, Acharya C et al. Automated determination of
urine and cerebrospinal fluid proteins with Coomassie Brilliant Blue and
the Abbott ABA-100. Clin Biochem 1980; 13: 81–83.
141. Marshall T, Williams KM. Total protein determination in urine: elimination
of a differential response between the coomassie blue and pyrogallol
red protein dye-binding assays. Clin Chem 2000; 46: 392–398.
142. Miller WG. Urine albumin: Recommendations for standardization. Scand J
Clin Lab Invest Suppl 2008; 241: 71–72.
143. Miller WG, Bruns DE, Hortin GL et al. Current issues in measurement and
reporting of urinary albumin excretion. Clin Chem 2009; 55: 24–38.
144. Medicines and Healthcare products Regulatory Agency. MHRA 04086
Point of care devices for the quantitation of microalbuminuria. 2004.
145. Medicines and Healthcare products Regulatory Agency. MHRA 04098.
Point of care devices for the detection and semi-quantitation of
microalbuminuria. 2004.
146. Parsons M, Newman DJ, Pugia M et al. Performance of a reagent strip
device for quantitation of the urine albumin: creatinine ratio in a point of
care setting. Clin Nephrol 1999; 51: 220–227.
147. Parsons MP, Newman DJ, Newall RG et al. Validation of a point-of-care
assay for the urinary albumin:creatinine ratio. Clin Chem 1999; 45: 414–417.
148. Graziani MS, Gambaro G, Mantovani L et al. Diagnostic accuracy of a
reagent strip for assessing urinary albumin excretion in the general
population. Nephrol Dial Transplant 2009; 24: 1490–1494.
149. Guy M, Newall R, Borzomato J et al. Diagnostic accuracy of the urinary
albumin: creatinine ratio determined by the CLINITEK Microalbumin and
DCA 2000 þ for the rule-out of albuminuria in chronic kidney disease.
Clin Chim Acta 2009; 399: 54–58.
150. Waugh JJ, Bell SC, Kilby MD et al. Optimal bedside urinalysis for the
detection of proteinuria in hypertensive pregnancy: a study of
diagnostic accuracy. BJOG 2005; 112: 412–417.
151. Iseki K, Iseki C, Ikemiya Y et al. Risk of developing end-stage renal disease
in a cohort of mass screening. Kidney Int 1996; 49: 800–805.
152. Kaplan RE, Springate JE, Feld LG. Screening dipstick urinalysis: a time to
change. Pediatrics 1997; 100: 919–921.
153. Kitagawa T. Lessons learned from the Japanese nephritis screening
study. Pediatr Nephrol 1988; 2: 256–263.
154. Boulware LE, Jaar BG, Tarver-Carr ME et al. Screening for proteinuria in
US adults: a cost-effectiveness analysis. JAMA 2003; 290: 3101–3114.
155. Bowie L, Smith S, Gochman N. Characteristics of binding between
reagent-strip indicators and urinary proteins. Clin Chem 1977; 23:
128–130.
156. Gyure WL. Comparison of several methods for semiquantitative
determination of urinary protein. Clin Chem 1977; 23: 876–879.
138 Kidney International Supplements (2013) 3, 136–150
references